Kantonsspital St.Gallen

Abbvie M14-423 An Open Label, Multicenter Study to Evaluate Long-Term Outcomes With ABT-450/Ritonavir/ABT-267 and ABT-333 With or Without Ribavirin in Adults With Genotyp 1 Chronic Hepatitis C Infection

David Semela, Patrizia Künzler Heule & Roman Stillhard

type of project clinical studies
status automatically closed
start of project 2015
end of project 2020
responsible person David Semela